Novel Oral miR-124 enhancer improves remission of refractory UC

(MedPage Today) – PHOENIX – A first-in-class oral miR-124 enhancer significantly improved clinical remission and endoscopic outcomes in patients with moderately to severely active ulcerative colitis (UC) who had failed multiple prior therapies.